Fig. 1From: Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancerFlow chart of evaluable clinical profiling in patients with primary PCa. PCa, prostate cancer; NEPC, neuroendocrine prostate cancer; ADT, androgen deprivation therapyBack to article page